Progress of clinical portfolio and strenghtnening of cash position.
Innate Pharma reports today its consolidated financial results for the year ending December 31, 2009.
Unaudited consolidated financial statements are attached to this press release.
| PR in english | 106.59 KB |
| CP en français | 106.43 KB |
| Slideshow financials for 2009 | 1.27 MB |